Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

Biohit Healthcare Ltd

Biohit Healthcare Ltd is part of a Finnish public company, which specialises in the development, manufacture and marketing of products and analysis systems for the early diagnosis and prevention of gastrointestinal diseases. Products include the blood-sample based GastroPanel examination for the diagnosis of stomach illnesses and associated risks, biopsy quick tests for the diagnosis of lactose intolerance and H. pylori infection in conjunction with gastroscopy, and Acetium which targets and neutralises acetaldehyde in an achlorhydric stomach.

Biohit Healthcare in the UK also represents a range of kit control products and an extensive range of ELISA immunology products. Please navigate this site to see more information on each product.

All these products are available directly and if you would like more information please use the contact form or call us on 0151 550 4 550

Biohit in brief

Biohit HealthCare is a globally operating biotechnology company that develops, manufactures and markets diagnostic tests and analysis systems. Our products are used by research and health care worldwide.
  • Established in 1988 by Professor Osmo Suovaniemi
  • Business area: Diagnostics
  • Headquartered in Finland, Helsinki
  • Subsidiaries located in Italy and UK
  • Production plant ís located in Finland
  • Biohit's products are sold by many distributors around the world
  • Biohit Oyj's share (BIOBV) is quoted on NASDAQ OMX Helsinki since June1999, Small cap/Healthcare

Innovations and patents

Biohit HealthCare's operations are based on a goal-oriented and long-term innovation and patenting strategy. Biohit works with scientific communities to produce new technologies, products and services based on research results and innovations that can be used to develop safe and cost-effective diagnostic tests for the early detection and prevention of diseases of the gastrointestinal tract.


Diagnostics

Biohit HealthCare has products and analysis systems for the early diagnosis of gastrointestinal diseases, such as the blood-sample based GastroPanel examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding (faecal occult blood) that indicates a risk of colorectal cancer. The Acetium innovation was developed to reduce carcinogenic acetaldehyde in the gastrointestinal tract. The key objective of the diagnostics business is to prevent diseases of the gastrointestinal tract.

Biohit Group worldwide

The Biohit Group employs around 50 people in four countries. The company is headquartered in Helsinki, Finland, and has subsidiary in China, Italy and the UK. Additionally, Biohit's products are sold by many distributors around the world.


Biohit Oyj on the stock exchange

Biohit's series B share (BIOBV) is quoted on NASDAQ OMX Helsinki, Small cap/Healthcare since 1999. More information about the share and financials is available in the Investors section of this site.